Xilio Therapeutics Inc (XLO)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2025-01-02 | VP Vente planifiée |
SVP, FINANCE AND ACCOUNTING Dirigeant |
1 803
-36.1%
0,981 774 USD |
1 803 -36.1% | 0,98 | 1 774 USD | |
| 2025-01-03 | 2025-01-02 | VP Vente planifiée |
Frankenfield Christopher James Chief Financial Officer Dirigeant |
6 954
-35.9%
0,986 841 USD |
6 954 -35.9% | 0,98 | 6 841 USD | |
| 2024-12-19 | 2024-12-18 | A Achat | Actionnaire important |
1 759 978
+24.0%
1,041 830 377 USD |
1 759 978 +24.0% | 1,04 | 1 830 377 USD | |
| 2024-04-03 | 2024-04-02 | A Achat | Actionnaire important |
485 250
+7.1%
0,76368 790 USD |
485 250 +7.1% | 0,76 | 368 790 USD | |
| 2024-02-09 | 2024-02-08 | V Vente | Actionnaire important |
267
-0.0%
0,64171 USD |
267 -0.0% | 0,64 | 171 USD | |
| 2024-02-09 | 2024-02-08 | V Vente | Actionnaire important |
733
-0.0%
0,64469 USD |
733 -0.0% | 0,64 | 469 USD | |
| 2024-01-16 | 2024-01-12 | V Vente | Actionnaire important |
560
-0.1%
0,83465 USD |
560 -0.1% | 0,83 | 465 USD | |
| 2024-01-16 | 2024-01-12 | V Vente | Actionnaire important |
1 540
-0.1%
0,831 278 USD |
1 540 -0.1% | 0,83 | 1 278 USD | |
| 2024-01-16 | 2024-01-11 | V Vente | Actionnaire important |
569
-0.1%
0,87495 USD |
569 -0.1% | 0,87 | 495 USD | |
| 2024-01-16 | 2024-01-11 | V Vente | Actionnaire important |
1 566
-0.1%
0,871 362 USD |
1 566 -0.1% | 0,87 | 1 362 USD | |
| 2021-12-10 | 2021-12-10 | A Achat |
Bain Capital Life Sciences Investors, LLC Actionnaire important |
3 188
+0.1%
10,2432 638 USD |
3 188 +0.1% | 10,24 | 32 638 USD | |
| 2021-12-10 | 2021-12-10 | A Achat |
Bain Capital Life Sciences Investors, LLC Actionnaire important |
21 812
+0.8%
9,56208 564 USD |
21 812 +0.8% | 9,56 | 208 564 USD | |
| 2021-12-10 | 2021-12-09 | A Achat |
Bain Capital Life Sciences Investors, LLC Actionnaire important |
4 011
+0.1%
9,8439 485 USD |
4 011 +0.1% | 9,84 | 39 485 USD | |
| 2021-12-10 | 2021-12-08 | A Achat |
Bain Capital Life Sciences Investors, LLC Actionnaire important |
13 458
+0.5%
9,62129 474 USD |
13 458 +0.5% | 9,62 | 129 474 USD | |
| 2021-10-28 | 2021-10-26 | A Achat | Actionnaire important |
387 500
+51.2%
16,006 200 000 USD |
387 500 +51.2% | 16,00 | 6 200 000 USD | |
| 2021-10-28 | 2021-10-26 | A Achat | Actionnaire important |
387 500
+51.2%
16,006 200 000 USD |
387 500 +51.2% | 16,00 | 6 200 000 USD | |
| 2021-10-26 | 2021-10-26 | A Achat | Actionnaire important |
187 500
+34.2%
16,003 000 000 USD |
187 500 +34.2% | 16,00 | 3 000 000 USD | |
| 2021-10-26 | 2021-10-26 | A Achat |
Rock Springs Capital Management LP Actionnaire important |
500 000
+66.1%
16,008 000 000 USD |
500 000 +66.1% | 16,00 | 8 000 000 USD | |
| 2021-10-26 | 2021-10-26 | A Achat | Actionnaire important |
312 500
+38.3%
16,005 000 000 USD |
312 500 +38.3% | 16,00 | 5 000 000 USD | |
| 2021-10-26 | 2021-10-26 | A Achat |
RiverVest Venture Fund IV, L.P. Actionnaire important |
250 000
+21.0%
16,004 000 000 USD |
250 000 +21.0% | 16,00 | 4 000 000 USD |